We see a common pattern at Tidal Wave Wellness — women in their 40s and early 50s who come in with joint aches, tendon pain, morning stiffness, or a general feeling that their body has changed in ways they can't quite explain. No acute injury. No structural diagnosis. Just a body that feels different than it did a few years ago.
In many of these cases, the answer — at least in part — is perimenopause.
Perimenopause is the transitional period before menopause during which the ovaries gradually produce less estrogen, progesterone, and testosterone. This transition typically begins in a woman's mid-40s, though it can start earlier, and it can last anywhere from two to twelve years before menopause is officially reached (defined as 12 consecutive months without a menstrual period).
Most people are familiar with hot flashes and mood changes as symptoms of this transition. Far fewer understand the profound effects that falling hormone levels — particularly estradiol, the most biologically active form of estrogen — have on the musculoskeletal system: the muscles, joints, tendons, ligaments, and bones that allow you to move through the world.
This is not "just getting older." This is a specific hormonal mechanism with a specific explanation — and importantly, with specific, evidence-backed interventions that can make a real difference.
Why Estrogen Matters for Your Muscles, Joints, and Connective Tissues
Estrogen is not just a reproductive hormone. Estrogen receptors are present throughout the musculoskeletal system — in muscle cells, synovial joint tissue, cartilage, tendons, ligaments, and bone. When estrogen levels fall, the effects are felt across all of these tissues simultaneously.
Estrogen and Inflammation Regulation
One of estrogen's most important but least-discussed functions is its role as a natural anti-inflammatory agent. Estrogen suppresses the production of pro-inflammatory cytokines, including interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and interleukin-1 beta (IL-1β) — the molecular messengers that drive joint inflammation, tissue swelling, and pain signaling.
As estradiol levels decline during perimenopause, this anti-inflammatory protection diminishes. The result is a state of increased systemic inflammation — often described by patients as diffuse joint aching, morning stiffness that takes longer to resolve, and a general feeling of being "inflamed." This is not imagined. It is measurable in inflammatory biomarkers and well-documented in the research literature.
Collagen, Tendons, and Ligament Integrity
Estrogen plays a critical role in collagen synthesis and the maintenance of connective tissue. Collagen is the structural protein that gives tendons, ligaments, cartilage, and skin their strength and elasticity. Estrogen stimulates collagen-producing cells (fibroblasts) and helps regulate the balance between collagen synthesis and breakdown.
When estrogen declines, collagen production decreases, and the extracellular matrix — the structural scaffolding of connective tissue — becomes less robust. Tendons can become more brittle and less resilient, increasing injury risk. Ligaments may become less supportive, contributing to joint instability and pain. Cartilage, which contains estrogen receptors and depends on estrogen for maintenance, begins to degrade more rapidly.
This explains why women in perimenopause often experience tendinopathies (particularly in the rotator cuff, hip, and knee) at higher rates than they did in earlier decades — even when they haven't changed their activity level. The tissue has changed, even if the demands on it haven't.
Muscle Mass, Strength, and Metabolic Function
Estrogen supports muscle protein synthesis and helps maintain muscle cell health. As estrogen declines, the process of sarcopenia — the age-related loss of muscle mass and strength — accelerates. Research suggests that women can lose significant amounts of muscle mass in the perimenopausal years, with some studies showing losses of 1–2% of lean mass per year during the transition.
Testosterone, which also declines during perimenopause, is an additional driver of muscle loss. Testosterone has direct anabolic effects on muscle tissue regardless of sex — its decline compounds the effect of falling estrogen on muscle mass and strength. The net result is that strength, exercise tolerance, and recovery capacity can all diminish noticeably during the perimenopausal transition, even in women who continue to train consistently.
Bone Density and Fracture Risk
Estrogen is the primary regulator of bone remodeling in women. It suppresses osteoclast activity (the cells that break bone down) and supports osteoblast activity (the cells that build bone up). As estrogen falls, this balance shifts dramatically — bone resorption outpaces bone formation, and bone mineral density declines at an accelerated rate.
The most rapid bone loss in women's lives occurs during the early postmenopausal years, but the process begins during perimenopause. Up to 20% of total bone mineral density can be lost in the five to seven years following menopause. This is why proactive intervention during the perimenopausal window — not waiting until postmenopause to start addressing bone health — is so important.
Recognizing the Musculoskeletal Syndrome of Menopause
Researchers have coined the term "musculoskeletal syndrome of menopause" to describe the cluster of symptoms that emerge from these hormonal changes: diffuse joint pain, tendon irritability, reduced grip strength, increased injury risk, and slower recovery. It is now estimated that up to 70% of women in the menopausal transition experience some form of musculoskeletal symptoms.
Critically, many women — and even some clinicians — attribute these symptoms solely to age. But the timing is important: these symptoms often begin years before menopause, during the perimenopausal transition, when hormone levels are fluctuating rather than simply declining. The hormonal origin of these symptoms matters because it points toward specific solutions that purely "aging"-focused approaches miss.
Evidence-Backed Strategies: What Actually Helps
Comprehensive Hormonal Assessment
The starting point for anyone experiencing symptoms that may be hormonally driven is a thorough hormonal blood panel. At Tidal Wave Wellness, our women's wellness panels assess FSH and LH levels (which rise as the ovaries produce less estrogen), estradiol, testosterone, SHBG (sex hormone binding globulin), DHEA-S, progesterone, thyroid function, cortisol, and metabolic markers. This gives us a complete picture of where you are in the hormonal transition and which systems are most affected.
Understanding your hormone levels is not just about knowing whether you're "in perimenopause" — it's about building a precise, individualized picture of your hormonal environment so that interventions can be targeted accurately. A woman with severely low estradiol who is losing bone density at an accelerated rate needs a different approach than a woman whose primary issue is testosterone deficiency affecting muscle mass and libido.
Menopausal Hormone Therapy (MHT)
Menopausal hormone therapy has been one of the most scrutinized and misunderstood interventions in medicine. The Women's Health Initiative (WHI) study published in 2002 created widespread fear about MHT that, in retrospect, was disproportionate to the actual risk profile — particularly for younger, healthier women beginning therapy close to menopause onset. Subsequent reanalysis and decades of additional research have substantially rehabilitated MHT's reputation among clinicians.
The North American Menopause Society (NAMS) now states that MHT is the most effective treatment for vasomotor symptoms (hot flashes, night sweats) and has meaningful benefits for bone density, joint pain, cardiovascular risk (when initiated early in the menopausal transition), and quality of life. For women without specific contraindications, the benefit-risk ratio of MHT initiated in the perimenopausal window is generally favorable.
Specifically relevant to musculoskeletal health, estrogen-alone therapy was shown in the WHI Estrogen-Alone trial to modestly but significantly reduce joint pain in participants. Multiple other studies have confirmed estrogen's benefits for cartilage preservation, tendon health, and the prevention of accelerated sarcopenia during the menopausal transition.
At Tidal Wave Wellness, our clinician-led approach to hormone optimization is individualized, evidence-based, and built on monitoring. We assess your baseline, discuss your personal risk profile, and monitor your response — adjusting as needed over time.
Testosterone Optimization
Testosterone therapy in women remains an underutilized tool, despite meaningful evidence for its benefits in perimenopausal and postmenopausal women. Low-dose testosterone supplementation has been shown to improve muscle mass and strength, support libido and mood, enhance cognitive function, and contribute to bone mineral density preservation.
Many women going through perimenopause are experiencing significant testosterone decline alongside estrogen loss — and the symptoms of low testosterone (reduced motivation, loss of lean mass, diminished energy, decreased libido) are often less visible than hot flashes but no less impactful on quality of life. Appropriate evaluation and, when indicated, low-dose testosterone therapy is part of a comprehensive hormone optimization approach.
Peptide Therapy to Support Tissue Health
For women looking for additional support for connective tissue integrity, muscle recovery, and anti-inflammatory activity, certain peptide therapies can be valuable adjuncts during the perimenopausal transition. BPC-157 and TB-500, for example, have demonstrated meaningful tissue repair and anti-inflammatory properties in preclinical and clinical research, and are increasingly used in regenerative medicine contexts. Growth hormone-stimulating peptides such as ipamorelin or CJC-1295 can help restore the nocturnal growth hormone pulse that supports lean mass maintenance and tissue recovery.
These are not replacements for addressing the underlying hormonal picture — but for women who are already optimizing their hormone status and still struggling with musculoskeletal recovery, peptide therapy can provide meaningful additional support.
Resistance Training as Non-Negotiable Medicine
The evidence for resistance training during perimenopause is overwhelming. Multiple meta-analyses confirm that regular progressive resistance training — two to three sessions per week — significantly improves muscle strength, bone mineral density, joint function, and quality of life in perimenopausal and postmenopausal women. The effects are independent of MHT but synergistic with it.
The key word is progressive — the load must increase over time to continue stimulating bone and muscle adaptation. This doesn't mean training to exhaustion; it means training with enough intensity to signal the body to maintain and build tissue. Compound movements (squats, deadlifts, rows, presses) are particularly effective for stimulating bone density and preserving functional muscle across the entire body.
Nutritional Support
Nutrition during perimenopause warrants specific attention to several key areas:
- Protein intake: Adequate protein is essential for maintaining lean mass during a period when anabolic hormones are declining. Most active perimenopausal women benefit from 1.2–1.6 grams of protein per kilogram of body weight daily — toward the higher end if muscle mass preservation is a priority.
- Calcium and vitamin D: Critical for bone mineral density. Vitamin D3 (2000–5000 IU daily, adjusted to achieve serum 25-OH vitamin D levels of 50–70 ng/mL) combined with calcium from food and/or supplementation is a foundational bone support strategy.
- Omega-3 fatty acids: Reduce systemic inflammation and may help preserve muscle mass during the transition.
- Collagen peptides: Emerging research suggests collagen supplementation combined with vitamin C may support tendon and ligament health during periods of increased connective tissue vulnerability.
- Magnesium: Supports muscle function, sleep quality, and plays a role in bone metabolism.
The Timeline Matters: Acting in the Window
One of the most important concepts in perimenopausal medicine is the "window of opportunity" — the idea that interventions initiated during the perimenopausal transition, rather than years into postmenopause, have significantly greater protective effects on bone, cardiovascular health, cognitive function, and tissue integrity.
This is not an argument for panicking — it is an argument for not waiting until symptoms become severe before seeking evaluation and developing a proactive plan. The women who navigate perimenopause most successfully are those who address it early, with a comprehensive, clinician-led approach rather than a reactive, symptom-by-symptom one.
Perimenopause is not a disease — it is a transition. But like any major physiological transition, navigating it well requires understanding what's happening in your body and having a thoughtful, personalized strategy in place. You don't have to simply endure it.
Take the First Step
At Tidal Wave Wellness, we work with women across the perimenopausal and menopausal transition with a clinician-led, data-driven approach. We begin with comprehensive lab work, take a detailed history of your symptoms and health goals, and build an individualized protocol that may include hormone monitoring and optimization, peptide therapy, targeted supplementation, and lifestyle guidance.
You deserve to feel strong, mobile, and like yourself — at every stage of life. If you're experiencing unexplained musculoskeletal symptoms, changes in body composition, fatigue, or other signs of the perimenopausal transition, schedule a consultation with our clinical team today. We'll help you understand what's happening and design a plan that works for you.